Skip to main content
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Nat Chem Biol. 2020 Feb 24;16(5):577–586. doi: 10.1038/s41589-020-0484-2

Figure 1.

Figure 1.

(a) Schematic representation of the MaMTH-DS platform workflow. (b) Dose response curves for the top three candidate EGFR L858R/T790M/C797S inhibitors (midostaurin, AZD7762 and Chembridge 5213777) showing robust, dose-responsive and mutant specific inhibition. Results are shown as the average ± SD for three independent experiments.